Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study.
Something Old, New, Borrowed, Blue: Anthracenedione Agents for Treatment of Multiple Sclerosis.
Acquired immune demyelinating neuropathies.
Delayed initial recovery and long lie following a fall among middle-aged and older adults with multiple sclerosis.
Brain atrophy at onset and physical disability in multiple sclerosis.
Sustained-release fampridine and the role of ion channel dysfunction in multiple sclerosis.
Teriflunomide for the treatment of multiple sclerosis.
Modulation by melatonin of the pathogenesis of inflammatory autoimmune diseases.
The role of IL-2 in the activation and expansion of regulatory T-cells and the development of experimental autoimmune encephalomyelitis.
Gait and six-minute walk performance in persons with multiple sclerosis.
Clinical Importance of Steps Taken per Day among Persons with Multiple Sclerosis.
Targeting calpain-mediated proteolysis and peptide signaling as a strategy to reduce injury in multiple sclerosis.
Alemtuzumab and multiple sclerosis: Is it safe?
Cortical thickness and surface area relate to specific symptoms in early relapsing-remitting multiple sclerosis.
STAT1-induced ASPP2 transcription identifies a link between neuroinflammation, cell polarity, and tumor suppression.
Synthesis of genistein coupled with sugar derivatives and their inhibitory effect on nitric oxide production in macrophages.
Body size and the risk of multiple sclerosis in Norway and Italy: The EnvIMS study.
Phenytoin in acute optic neuritis: neuroprotective or not?
Reduced Dual-Task Performance in MS Patients Is Further Decreased by Muscle Fatigue.
Modeling the variability in brain morphology and lesion distribution in multiple sclerosis by deep learning.
A systematic review and meta-analysis of strength training in individuals with multiple sclerosis or Parkinson disease.
Cortical remyelination: A new target for repair therapies in multiple sclerosis.
Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
Revisiting the management of fatigue in multiple sclerosis in the context of rehabilitation: a narrative review of current evidence.
CRYAB modulates the activation of CD4+ T cells from relapsing-remitting multiple sclerosis patients.

Pages